Business Context and Reporting Period
Company: Graham Holdings Company (GHC)
Filing Type: Form 10-Q (Unaudited)
Reporting Period: Quarter and six months ended June 30, 2024
Business Overview: A diversified holding company with segments in Education (Kaplan), Television Broadcasting, Manufacturing, Healthcare, Automotive, and Other Businesses (including media, retail, and restaurants).
Key Financial Metrics
| Metric (in thousands) | Q2 2024 | Q2 2023 | 6M 2024 | 6M 2023 |
|---|---|---|---|---|
| Operating Revenues | $1,185,280 | $1,104,999 | $2,337,942 | $2,136,545 |
| Operating Income | $25,911 | $58,055 | $61,353 | $85,711 |
| Net Income (Loss) Attributable to GHC | $(21,040) | $122,788 | $103,340 | $175,060 |
| Diluted EPS | $(4.79) | $25.89 | $23.11 | $36.67 |
| Operating Cash Flow (6M) | $53,108 | $62,239 | $53,108 | $62,239 |
| Total Debt | $834,772 | $811,833 | $834,772 | $811,833 |
| Cash & Cash Equivalents | $140,717 | $169,897 | $140,717 | $169,897 |
Note: Q2 2024 Net Loss includes significant non-operating items detailed below.
Material Changes vs. Prior Period
- Revenue Growth: Total revenue increased 7% in Q2 2024 and 9% in the first six months of 2024 compared to the prior year. Growth was driven by Education (+5% Q2), Healthcare (+30% Q2), and Automotive (+18% Q2), partially offset by declines in Manufacturing (-14% Q2) and Other Businesses (-4% Q2).
- Operating Income Decline: Operating income fell 55% in Q2 2024 and 28% in the first six months of 2024. This decrease is primarily attributed to a $26.3 million impairment charge at World of Good Brands (WGB) and declines in the Manufacturing and Other Businesses segments.
- Net Income Volatility: The company reported a net loss in Q2 2024 compared to significant net income in Q2 2023. This swing is largely due to:
- Interest Expense Adjustment: A $73.5 million expense recorded in Q2 2024 to adjust the fair value of mandatorily redeemable noncontrolling interest (vs. a $1.2 million credit in Q2 2023).
- Investment Gains: Net gains on marketable equity securities were $19.6 million in Q2 2024, down from $78.6 million in Q2 2023.
- One-time Gains: Q2 2023 included a $10.0 million gain on the sale of the Pinna business, which was not present in 2024.
- Segment Performance:
- Education: Kaplan International revenue grew 12% (Q2) driven by growth in Australia, UK, and Singapore. Higher Education revenue declined 10% due to timing of fees from Purdue Global.
- Healthcare: Revenue surged 30% (Q2) due to expansion of infusion treatments at CSI Pharmacy.
- Automotive: Revenue increased 18% (Q2) due to the acquisition of Toyota of Richmond and the addition of a Kia dealership.
- Other Businesses: Significant operating losses driven by WGB impairment and continued weakness in digital advertising demand.
Guidance, Outlook, and Risks
- Capital Expenditures: Management estimates 2024 capital expenditures will range between $95 million and $105 million.
- Dividends: The company expects to pay a total dividend of $6.88 per share in 2024. Regular dividends of $1.72 per share were declared in Q2 2024.
- Share Repurchases: The company repurchased approximately $50.0 million of Class B common stock in the first six months of 2024. As of June 30, 2024, $167,617 shares remain authorized for repurchase under the current plan.
- Liquidity: The company maintains $167.8 million in undrawn capacity on its $300 million revolving credit facility. Management believes existing cash and internally generated funds are sufficient to meet requirements for the next 12 months.
- Risks and Contingencies:
- Impairment Risk: Management notes that further material impairment charges could occur due to changes in market conditions, specifically citing the digital advertising market.
- Legal: Management estimates reasonably possible future losses from legal proceedings could reach approximately $10 million.
- Interest Rates: Net interest expense increased significantly due to higher debt balances and variable interest rates, alongside the fair value adjustment of noncontrolling interests.
Investor Verification Checklist
- Impairment Details: Verify the specific cash flow assumptions and discount rates used in the $26.3 million WGB impairment calculation.
- Noncontrolling Interest Adjustment: Review the methodology for the $73.5 million interest expense adjustment related to the fair value of mandatorily redeemable noncontrolling interests in the healthcare segment.
- Pension Plan Funding: Confirm the impact of the Voluntary Retirement Incentive Program (VRIP) and Separation Incentive Programs (SIPs) on future pension obligations and cash flows.
- Investment Portfolio: Assess the concentration risk in marketable equity securities, noting that Berkshire Hathaway and Markel Group holdings exceed 5% of total assets.
- Automotive Integration: Monitor the performance of the newly acquired Toyota of Richmond dealership and the new Kia dealership to ensure projected synergies are realized.